A first-in-man study to evaluate the safety, tolerability, and pharmacokinetics of pasireotide (SOM230), a multireceptor-targeted somatostatin analog, in healthy volunteers
Georg Golor1, Ke Hu2, Matthieu Ruffin3, Alexandra Buchelt3, Emmanuel Bouillaud3, Yanfeng Wang2, Mario Maldonado31Parexel International GmbH, Berlin, Germany; 2Novartis Pharmaceuticals, East Hanover, NJ, USA; 3Novartis Pharma AG, Basel, SwitzerlandAbstract: Pasireotide (SOM230) is a multireceptor-tar...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2012-04-01
|
| coleção: | Drug Design, Development and Therapy |
| Acesso em linha: | http://www.dovepress.com/a-first-in-man-study-to-evaluate-the-safety-tolerability-and-pharmacok-a9739 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|